Mirum Pharmaceuticals, Inc.

MIRM

NASDAQ

Healthcare

Biotechnology

Foster City, CA, US334 employeesmirumpharma.com

$94.39

+0.21(0.2%)

52W $38.39 – $108.62

AI-generated from 10-K FY2025 filed Feb 24, 2026

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Revenue breakdown: Product (74.7%), Livmarli (17.2%), Bile Acid Medicines (7.7%).

$4.7BMkt Cap

$521MRev TTM

-$23MNI TTM

-192.2xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 24, 2026

10-K for FY2025 was filed on 2026-02-25. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Financial ResultsFeb 24, 2026

Results of Operations and Financial Condition. On February 25, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) issued a press release providing a corporate up

View filing →

Asset Acquisition+3 MoreJan 25, 2026

Completion of Acquisition or Disposition of Assets. On January 23, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) completed the previously announced acquisit

View filing →

Financial ResultsJan 11, 2026

Results of Operations and Financial Condition. On January 12, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) issued a press release announcing, among other t

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Product74.7%($3.1B)

Livmarli17.2%($715M)

Bile Acid Medicines7.7%($321M)

License And Other Revenue0.4%($16M)

Revenue by Geography

US79.3%($822M)

Non Us20.7%($214M)

Peer Companies

Company	Price	Change	Market Cap	P/E
BLTEBelite Bio, Inc	$173.64	+2.23%	$6.8B	-65.3
PRAXPraxis Precision Medicine...	$319.07	+2.80%	$6.7B	-21.8
LGNDLigand Pharmaceuticals, I...	$205.08	+2.75%	$4.1B	31.8
ACADACADIA Pharmaceuticals In...	$22.63	+1.94%	$3.9B	9.1
DYNDyne Therapeutics, Inc.	$18.80	-0.21%	$3.1B	-5.1
TLXTelix Pharmaceuticals Lim...	$9.12	-0.11%	$3.1B	-390.0
TVTXTravere Therapeutics, Inc...	$33.03	+8.53%	$3.0B	-49.9
SLNOSoleno Therapeutics, Inc.	$52.20	+32.17%	$2.8B	80.7

Company Profile

CIK0001759425

ISINUS6047491013

CUSIP604749101

Phone650 667 4085

Address950 Tower Lane, Foster City, CA, 94404, US

SEC EDGAR